Summary: Corticosteroid inhalers are a common cause of dysphonia and their use should be investigated in any patient with laryngeal complaints.

Inhaled corticosteroids are associated with an increased occurrence of dysphonia. Any evaluation of dysphonia should consider use of ICS or other ...

For a long time, local adverse effects of inhaled corticosteroid therapy have been supposed to be the cause of dysphonia.

Common symptoms include pharyngitis, hoarseness, throat clearing, and cough. These symptoms occur with all steroid inhalant preparations, and appear to be dose ...

A common local adverse effect of ICS therapy is dysphonia, which has been reported to affect 5% to 58% of patients.

Nine of 14 asthmatic patients who presented with persistent dysphonia while taking inhaled corticosteroids had a bilateral adductor vocal cord deformity ...

7 сент. 2023 г. · Dysphonia — Dysphonia (hoarse voice) is a common complaint among users of inhaled glucocorticoids (ICS). Reported incidences vary from 1 to 60 ...

Some studies have described cases of dysphonia and laryngeal lesions in adult patients under chronic use of steroids and other inhalation medication to treat ...

Inhaled corticosteroid (ICS) therapy has become standard in the treatment of asthma. A common local adverse effect of ICS therapy is dysphonia, ...